Newsletter Archive
-
08.26.24 -- Solutions For mRNA And Nanoparticle Manufacturing
8/26/2024
08/26/24 Advancing RNA Newsletter
-
08.21.24 -- Innovation Advances In mRNA Medicine
8/21/2024
08/21/24 Advancing RNA Newsletter
-
08.21.24 -- Simplifying Preclinical Development And Scale Up Of Lipid Nanoparticles
8/21/2024
08/21/24 Advancing RNA Newsletter
-
08.14.24 -- Ophthalmic Drug Delivery
8/14/2024
08/14/24 Advancing RNA Newsletter
-
08.07.24 -- A "Hot Take" On mRNA CPPs
8/7/2024
08/07/24 Advancing RNA Newsletter
-
07.31.24 -- What Does FDA's Platform Guidance Mean For ATMP Companies?
7/31/2024
07/31/24 Advancing RNA Newsletter
-
07.30.24 -- Maximize The Potential Of Your mRNA-Based Therapeutics
7/30/2024
07/30/24 Advancing RNA Newsletter
-
07.24.24 -- Two "Hot Takes" On mRNA Delivery
7/24/2024
07/24/24 Advancing RNA Newsletter
-
07.22.24 -- Manufacturing LNPs And mRNA-Based Vaccines
7/22/2024
07/22/24 Advancing RNA Newsletter
-
07.17.24 -- Assessing Lipid Quality For LNP Manufacturing
7/17/2024
07/17/24 Advancing RNA Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more